Tbx3基因在肿瘤进展中的机制研究

国际肿瘤学杂志››2015,Vol. 42››Issue (1): 37-39.doi:10.3760/cma.j.issn.1673-422X.2015.01.009

Tbx3基因在肿瘤进展中的机制研究

单泽志, 严雪冰, 田源, 金志明

200233上海交通大学附属第六人民医院普外科

收稿日期:2014-06-03修回日期:2014-07-11出版日期:2015-01-08发布日期:2015-01-07
通讯作者:金志明 E-mail:jzmgyp@aliyun.com

Mechanism research of Tbx3 gene in tumor progression

Shan Zezhi, Yan Xuebing, Tian Yuan, Jin Zhiming

Department of General Surgery, Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200233, China

Received:2014-06-03Revised:2014-07-11Online:2015-01-08Published:2015-01-07
Contact:Jin Zhiming E-mail:jzmgyp@aliyun.com

摘要/Abstract

摘要：Tbx3(T-box3)基因作为T-box家族的成员之一，广泛存在于人体的多种组织和器官中，参与了胚胎时期乳腺、四肢、心脏、眼、肺、胰腺的发育调控，并且在维持胚胎干细胞的发育中发挥了重要作用。最新研究表明，Tbx3可以作为转录因子通过上皮间质转化、肿瘤干细胞和甲基化等多种途径参与肿瘤的发生和发展。更好地了解Tbx3将为肿瘤的基因诊断和靶向治疗提供新的思路。

关键词:肿瘤干细胞,甲基化,Tbx3,上皮间质转化

Abstract:As a member of Tbox family, Tbx3 (Tbox3) is widely expressed in multiple organs and involves in the development of breast, limb, heart, eye, lung and pancreas during embryonic development stage. Moreover, Tbx3 plays an important role in maintaining the embryonic stem cells. Recent studies show that Tbx3 can work as a transcription factor to participate in the initiation and progression of tumor by epithelialmesenchymal transition, induction tumor stemness and methylation. A better understanding of Tbx3 will provide new insights into genetic diagnosis and targeted treatment of tumor.

Key words:Neoplastic stem cells,Methylation,Tbx3,Epithelial-mesenchymal transition

单泽志, 严雪冰, 田源, 金志明. Tbx3基因在肿瘤进展中的机制研究[J]. 国际肿瘤学杂志, 2015, 42(1): 37-39.

Shan Zezhi, Yan Xuebing, Tian Yuan, Jin Zhiming. Mechanism research of Tbx3 gene in tumor progression[J]. Journal of International Oncology, 2015, 42(1): 37-39.

参考文献

［1］ Washkowitz AJ, Gavrilov S, Begum S, et al. Diverse functional networks of Tbx3 in development and disease［J］. Wiley Interdiscip Rev Syst Biol Med, 2012, 4(3): 273-283. ［2］ Gavrilov S, Harvey RP, Papaioannou VE. Lack of genetic interaction between Tbx20 and Tbx3 in early mouse heart development［J］. PLoS One, 2013, 8(7): e70149. ［3］ Douglas NC, Papaioannou VE. The Tbox transcription factors TBX2 and TBX3 in mammary gland development and breast cancer［J］. J Mammary Gland Biol Neoplasia, 2013, 18(2): 143-147. ［4］ Ballim RD, Mendelsohn C, Papaioannou VE, et al. The ulnarmammary syndrome gene, Tbx3, is a direct target of the retinoic acid signaling pathway, which regulates its expression during mouse limb development［J］. Mol Biol Cell, 2012, 23(12): 2362-2372. ［5］ Hoogaars WM, Engel A, Brons JF, et al. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria［J］. Genes Dev, 2007, 21(9): 1098-1112. ［6］ Lu R, Yang A, Jin Y. Dual functions of Tbox 3 (Tbx3) in the control of selfrenewal and extraembryonic endoderm differentiation in mouse embryonic stem cells［J］. J Biol Chem, 2011, 286(10): 8425-8436. ［7］ Weidgang CE, Russell R, Tata PR, et al. TBX3 directs cellfate decision toward mesendoderm［J］. Stem Cell Reports, 2013, 1(3): 248265. ［8］ Guo F, Parker Kerrigan BC, Yang D, et al. Posttranscriptional regulatory network of epithelialtomesenchymal and mesenchymaltoepithelial transitions［J］. J Hematol Oncol, 2014, 7: 19. ［9］ Rodriguez M, Aladowicz E, Lanfrancone L, et al. Tbx3 represses Ecadherin expression and enhances melanoma invasiveness［J］. Cancer Res, 2008, 68(19): 7872-7881. ［10］ Boyd SC, Mijatov B, Pupo GM, et al. Oncogenic BRAF(V600E) signaling induces the TBox3 transcriptional repressor to repress Ecadherin and enhance melanoma cell invasion［J］. J Invest Dermatol, 2013, 133(5): 12691277. ［11］ Du HF, Ou LP, Yang X, et al. A new PKCα/β/TBX3/Ecadherin pathway is involved in PLCεregulated invasion and migration in human bladder cancer cells［J］. Cell Signal, 2014, 26(3): 580-593. ［12］ Yu Z, Pestell TG, Lisanti MP, et al. Cancer stem cells［J］. Int J Biochem Cell Biol, 2012, 44(12): 2144-2151. ［13］ Amini S, Fathi F, Mobalegi J, et al. The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines［J］. Anat Cell Biol, 2014, 47(1): 1-11. ［14］ Fillmore CM, Gupta PB, Rudnick JA, et al. Estrogen expands breast cancer stemlike cells through paracrine FGF/Tbx3 signaling［J］. Proc Natl Acad Sci USA, 2010, 107(50): 21737-21742. ［15］ Liu J, Esmailpour T, Shang X, et al. TBX3 overexpression causes mammary gland hyperplasia and increases mammary stemlike cells in an inducible transgenic mouse model［J］. BMC Dev Biol, 2011, 11: 65. ［16］ Renard CA, Labalette C, Armengol C, et al. Tbx3 is a downstream target of the Wnt/betacatenin pathway and a critical mediator of betacatenin survival functions in liver cancer［J］. Cancer Res, 2007, 67(3): 901-910. ［17］ Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer［J］. Oncogene, 2010, 29(34): 4741-4751. ［18］ Chiou SH, Wang ML, Chou YT, et al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem celllike properties and epithelialmesenchymal transdifferentiation［J］. Cancer Res, 2010, 70(24): 10433-10444. ［19］ Asiedu MK, BeauchampPerez FD, Ingle JN, et al. AXL induces epithelialtomesenchymal transition and regulates the function of breast cancer stem cells［J］. Oncogene, 2014, 33(10): 13161324. ［20］ Mani SA, Guo W, Liao MJ, et al. The epithelialmesenchymal transition generates cells with properties of stem cells［J］. Cell, 2008, 133(4): 704-715. ［21］ Lan L, Luo Y, Cui D, et al. Epithelialmesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells［J］. Int J Oncol, 2013, 43(1): 113-120. ［22］ Masui T, Ota I, Yook JI, et al. Snailinduced epithelialmesenchymal transition promotes cancer stem celllike phenotype in head and neck cancer cells［J］. Int J Oncol, 2014, 44(3): 693-699. ［23］ Patai AV, Molnár B, Kalmár A, et al. Role of DNA methylation in colorectal carcinogenesis［J］. Dig Dis, 2012, 30(3): 310-315. ［24］ Kang C, Song JJ, Lee J, et al. Epigenetics: an emerging player in gastric cancer［J］. World J Gastroenterol, 2014, 20(21): 6433-6447. ［25］ Kandimalla R, van Tilborg AA, Kompier LC, et al. Genomewide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTaspecific prognostic markers［J］. Eur Urol, 2012, 61(6): 1245-1256. ［26］ Li J, Weinberg MS, Zerbini L, et al. The oncogenic TBX3 is a downstream target and mediator of the TGFβ1 signaling pathway［J］. Mol Biol Cell, 2013, 24(22): 3569-3576. ［27］ Burgucu D, Guney K, Sahinturk D, et al. Tbx3 represses PTEN and is overexpressed in head and neck squamous cell carcinoma［J］. BMC cancer, 2012, 12: 481. ［28］ Renard CA, Labalette C, Armengol C, et al. Tbx3 is a downstream target of the Wnt/betacatenin pathway and a critical mediator of betacatenin survival functions in liver cancer［J］. Cancer Res, 2007, 67(3): 901-910.

[1]	阎星羽, 廉振颖, 刁玉涛, 刘红艳.BMXΔN通过ERK/MAPK信号通路影响肺癌细胞对吉非替尼的耐药性[J]. 国际肿瘤学杂志, 2021, 48(6): 328-334.
[2]	魏永健, 胡进静, 李汛.CDCA8与肿瘤发生发展及干细胞干性维持的关系[J]. 国际肿瘤学杂志, 2021, 48(4): 216-219.
[3]	吴汉生, 黄树杰, 庄伟涛, 丁宇, 高枕, 乔贵宾.m⁶A甲基化修饰与肺癌[J]. 国际肿瘤学杂志, 2021, 48(4): 225-230.
[4]	邓波儿, 孔为民.子宫内膜癌的表观遗传学研究进展[J]. 国际肿瘤学杂志, 2021, 48(3): 184-188.
[5]	曾娟, 杨向红.N⁶-甲基腺嘌呤修饰调节因子与肿瘤[J]. 国际肿瘤学杂志, 2021, 48(2): 96-100.
[6]	赵丽丽, 赵文文, 冯青青, 赵文飞, 张雪, 井文君, 魏红梅.沉默PD-L1表达对胃癌细胞生物学行为的影响[J]. 国际肿瘤学杂志, 2021, 48(12): 705-710.
[7]	刘培培, 杨梦雪, 严雪冰.m⁶A甲基化修饰在消化系统肿瘤中的研究进展[J]. 国际肿瘤学杂志, 2021, 48(11): 688-692.
[8]	何苗, 范奎, 曹芳.表观遗传与肺癌耐药[J]. 国际肿瘤学杂志, 2021, 48(10): 622-626.
[9]	王宁菊, 陈冬梅, 章恒, 胡萍, 王燕.靶向沉默PRL-3基因对肺癌细胞增殖、迁移、侵袭及上皮间质转化的影响[J]. 国际肿瘤学杂志, 2021, 48(1): 18-23.
[10]	桑莹冰, 梁俊琴.皮肤鳞状细胞癌表观遗传学发病机制[J]. 国际肿瘤学杂志, 2020, 47(9): 569-572.
[11]	王丽丽, 赵松, 欧阳明玥, 谢晓冬, 邢思宁, 刘硕, 于卉影.多西他赛诱导的多倍体肿瘤细胞在肿瘤复发中的作用[J]. 国际肿瘤学杂志, 2020, 47(6): 340-345.
[12]	王坤龙, 张洋, 宿伟鹏, 刘攀, 赵化荣.LSD1和PDPN在舌鳞状细胞癌中的表达及对预后的影响[J]. 国际肿瘤学杂志, 2020, 47(5): 264-271.
[13]	尹剑云, 王培伟, 顾建伟.m⁶A甲基化与乳腺癌[J]. 国际肿瘤学杂志, 2020, 47(12): 752-755.
[14]	张千慧, 张洋, 宿伟鹏, 张宋安, 刘攀, 赵化荣.LSD1、MGMT和Ki-67在高级别胶质瘤中的表达及对预后的影响[J]. 国际肿瘤学杂志, 2019, 46(9): 519-525.
[15]	亢野,李建一,杨向红.三阴性乳腺癌干细胞研究进展[J]. 国际肿瘤学杂志, 2019, 46(6): 362-365.